Pfizer, Oxford vaccines reduce severe COVID-19 in elderly, study finds

The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed symptomatic disease in individuals aged 70 years or older in England.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/304NDbu
via IFTTT